Intriguingly, increased blood-derived fibrinogen deposition in human MS lesions increases Id protein expression in OPCs via the activation of BMP receptor signaling consequently blocking oligodendrocyte differentiation (Fig. 1) (Petersen et al. 2017). The gene discussed is ID1; the disease is myeloid sarcoma.